BiotechTube
Home/Treovir/G. Yancey Gillespie, PhD
GY

G. Yancey Gillespie, PhD

Founder and CSO

Treovir

Therapeutic Areas

OncologyPediatric Brain TumorsNeuro-Oncology

Treovir Pipeline

DrugIndicationPhase
G207Recurrent pediatric glioblastoma/gliomaPhase 2

Leadership Team at Treovir

MC
Michael Christini, JD
Founder and CEO
RW
Richard Whitley, MD
Founder and Advisor
JM
James Markert, MD
Founder and Advisor
View full Treovir profile